TCG Crossover Management LLC 13D/13G Filings for Tyra Biosciences, Inc. (TYRA)

TCG Crossover Management LLC 13D and 13G filings for Tyra Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-09-29
06:01 am
Unchanged		 2021-09-15 13G Tyra Biosciences, Inc.
TYRA		 TCG Crossover Management LLC 937,500
2.200%		 0
(Unchanged)		 Filing
2021-09-21
12:16 pm
Purchase		 2021-09-15 13G Tyra Biosciences, Inc.
TYRA		 TCG Crossover Management LLC 937,500
8.700%		 937,500increase
(New Position)		 Filing